Market Access Pricing and Reimbursement in Europe for an In-Vitro Diagnostic (IVD) Test

CHALLENGE

A top 10 pharmaceutical company engaged a boutique consulting firm to investigate market access, pricing, and reimbursement dynamics for an In-Vitro Diagnostic (IVD) test across Europe. The goal was to understand the key factors influencing market entry, pricing strategies, and reimbursement processes for IVD tests in diverse European markets.

BTHT APPROACH

Following a comprehensive briefing with the consulting firm and a detailed assessment of the project’s objectives, the BTHT team quickly identified and engaged relevant experts. They reached out to former payors and market access specialists with extensive experience in European healthcare systems. The BTHT team organized and facilitated a series of expert calls, ensuring that each discussion was insightful and technically smooth.

OUTCOME

The BTHT team effectively connected the client with seasoned former payors and market access experts, providing deep insights into the complexities of market access for IVD tests in Europe. The expert calls delivered valuable information on pricing strategies, reimbursement pathways, and the regulatory landscape across different European countries. This comprehensive analysis enabled the consulting firm to offer the pharmaceutical company a detailed and actionable assessment, crucial for navigating the European market and optimizing their IVD test’s market access strategy.